Samsung Biologics has leading production capacity at BIO International

SAN DIEGO — Samsung Biologics is showcasing its premier manufacturing capabilities at the world’s largest biopharmaceutical expo, the South Korean company announced Monday.

Attending the International BIO Convention for the 10th consecutive year, Samsung Biologics set up a 140 square meter booth to represent its world-leading production capability as one of the world’s largest contracting and arranging companies. manufacturing around the world.

According to Samsung Biologics, the booth has installed sensory lighting that detects visitors’ movements to highlight the company’s end-to-end services from the early stages of biopharmaceutical product development to the completion of commercial production. . It also has a kiosk and virtual reality devices to show off the company’s manufacturing facilities in Songdo, Incheon.

Samsung Biologics said it would seek to actively engage with global bio and pharma companies by co-sponsoring events at this year’s four-day convention.

Pierre Catignol, the company’s executive vice president, in charge of its manufacturing center, will lead a session on messenger RNA technology on the second day of the convention. The technology gained attention during the pandemic after two vaccines were developed using it, Catignol will discuss how the mRNA will be applied in other areas of medicine.

Back for its 29th edition, the annual bio convention is organized by the Biotechnology Innovation Organization. A total of 1,140 companies from all over the world participate in the exhibitions. More than 15,000 visitors are expected at the convention this year.

As a venue for networking and company presentations for the global bio industry, the event took place in major US cities with bio clusters. The previous two conventions were limited to online events due to the COVID-19 pandemic.

By Kan Hyeong-woo (hwkan@heraldcorp.com)